Brief: Abbisko Cayman Says Unit Received Upfront Payment Of $70 Mln for Licensing Deal
06/02/2024 24:03
Feb 6 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* UNIT RECEIVED UPFRONT PAYMENT OF $70 MILLION UPON ENTRY
INTO
LICENSING DEAL FOR PIMICOTINIB (ABSK021)
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Medicine
See all newsChina's Abbisko jumps on positive clinical trial results for achondroplasia drug
Brief: Abbisko Cayman Says Unit Completes First Patient Dosing In Phase I Trial Of ABSK211
Brief: Abbisko Cayman Gets IND Clearance From FDA For Oral Small Molecule Pan-Kras Inhibitor ABSK211
HK-listed Abbisko hits 7-week peak on AstraZeneca tie-up
Brief: Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration